Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Conditions: Brain Cancer; Glioblastoma; Metastatic Cancer; Leptomeningeal Metastasis; Recurrent Glioblastoma Interventions: Drug: Trastuzumab deruxtecan Sponsors: Memorial Sloan Kettering Cancer Center; AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Brain | Brain Cancers | Cancer | Cancer & Oncology | Herceptin | Neurology | Research